Enlarge / Woman on a kg weight scale Getty | BSIP
A repurposed Type 2 diabetes drug helped teens with obesity lose a significant amount of body weight, lowered their risk factors for cardiovascular disease, and improved their weight-related quality of life over a 68-week clinical trial, researchers reported this week in the New England Journal of Medicine.
The drug is semaglutide (brand name Wegovy), which was first approved to treat Type 2 diabetes in 2017, but has since also proven useful for weight loss in adults who are obese or overweight. The drug works by mimicking a hormone called
→ Continue reading at Ars Technica